Results 291 to 300 of about 409,331 (346)

Case Report: Renal metastasis of a gastric gastrointestinal stromal tumor mimicking a primary renal carcinoma. [PDF]

Front Oncol
Bao X, Chen C, Huang B.
europepmc   +1 more source

Giant gastric gastrointestinal stromal tumor: A case report. [PDF]

Int J Surg Case Rep
Neupane D, Pandit N.
europepmc   +1 more source

Pre-emptive purse-string suture for full-thickness resection of a gastrointestinal stromal tumor in the duodenal bulb: a case report. [PDF]

Endoscopy
Peng Y, Wu Z, Chen C, Ren Y, Feng X.
europepmc   +1 more source

Three-dimensional bioprinting of patient-derived Gastrointestinal stromal tumor: a novel platform for precision oncology and drug response profiling. [PDF]

J Nanobiotechnology
Du L, Zheng Z, Wang Y, Zhang K, Lu Y, Sun M, Pang M, Jiang S, He Y, Du S, Zhao H, Mao Y, Yang H, Kang W.   +13 more
europepmc   +1 more source

Overexpression of CD55 correlates with tumor progression and poor prognosis in gastric stromal tumors

, 2019
Yin X, Chen‐Yang Shen, Yongmei Yin, Zhaowei Cai, Jun Wang, Zihao Zhao, Daniel Chen, Zhuo Chen, Hui Chen, Bing Zhang   +9 more
openalex   +1 more source

Extracellular domain c-kit mutation with duplication of Ser501Ala502 found in gastrointestinal stromal tumors is more imatinib- and nilotinib-sensitive than that with duplication of Ala502Tyr503

, 2013
寧寧 劉
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Gastrointestinal stromal tumors

Abdominal Imaging, 2006
We reviewed radiologic features of gastrointestinal stromal tumors (GISTs) and correlated them with clinical and pathologic findings.We investigated a series of 39 c-Kit-positive GISTs. Clinical and radiologic findings and management of these patients were recorded.Twenty women and 19 men (mean age 64 years) had histologically proved GIST.
A, Darnell, E, Dalmau, C, Pericay, E, Musulén, J, Martín, J, Puig, A, Malet, E, Saigí, M, Rey   +8 more
openaire   +4 more sources

Gastrointestinal Stromal Tumors

Hematology/Oncology Clinics of North America, 2005
Gastrointestinal stromal tumors (GISTs) are identified pathologically by the expression of KIT. The management of GISTs has been altered significantly by the development of imatinib mesylate, a tyrosine kinase inhibitor with activity against KIT and platelet-derived growth factor receptors.
Margaret, von Mehren, James C, Watson
openaire   +2 more sources